Literature DB >> 25792003

EPAS1 Gene Polymorphisms Are Associated With High Altitude Polycythemia in Tibetans at the Qinghai-Tibetan Plateau.

Jin Xu1, Ying-Zhong Yang2, Feng Tang2, Qin Ga2, Wuren Tana2, Ri-Li Ge3.   

Abstract

OBJECTIVE: To test the hypothesis that the polymorphisms in the EPAS1 gene are associated with the susceptibility to high altitude polycythemia (HAPC) in Tibetans at the Qinghai-Tibetan Plateau.
METHODS: We enrolled 63 Tibetan HAPC patients and 131 matched healthy Tibetans as a control group, from the Yushu area in Qinghai where the altitude is greater than 3500 m. Eight single-nucleotide polymorphisms (SNPs) of the EPAS1 gene, including rs12619696, rs13420857, rs2881504, rs4953388, rs13419896, rs4953354, rs10187368, and rs7587138, were genotyped by the Sequenom MassARRAY SNP assay.
RESULTS: The frequencies of the G allele of EPAS1 SNP rs13419896 were significantly higher in the HAPC group than in the control group (P < .05). Moreover, the A alleles of rs12619696 and rs4953354 were prevalent in the HAPC group, and their counterpart homozygotes were prevalent in the normal Tibetan group (P < .05).
CONCLUSIONS: Compared with normal Tibetans, Tibetans with HAPC are maladapted and have a different haplotype in EPAS1 SNPs rs12619696, rs13419896, and rs4953354.
Copyright © 2015 Wilderness Medical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EPAS1; Tibetans; high altitude polycythemia; polymorphism

Mesh:

Substances:

Year:  2015        PMID: 25792003     DOI: 10.1016/j.wem.2015.01.002

Source DB:  PubMed          Journal:  Wilderness Environ Med        ISSN: 1080-6032            Impact factor:   1.518


  8 in total

1.  Targeted Sequencing Identifies the Genetic Variants Associated with High-altitude Polycythemia in the Tibetan Population.

Authors:  Zhiying Zhang; Lifeng Ma; Xiaowei Fan; Kun Wang; Lijun Liu; Yiduo Zhao; ZhiPeng Zhao; Han Zhang; Tian Liang; Wenxue Dong; Peng Cai; Yansong Li; Jing Li; Songhua Zhou; Longli Kang
Journal:  Indian J Hematol Blood Transfus       Date:  2021-08-03       Impact factor: 0.915

2.  Associations of high-altitude polycythemia with polymorphisms in PIK3CD and COL4A3 in Tibetan populations.

Authors:  Xiaowei Fan; Lifeng Ma; Zhiying Zhang; Yi Li; Meng Hao; Zhipeng Zhao; Yiduo Zhao; Fang Liu; Lijun Liu; Xingguang Luo; Peng Cai; Yansong Li; Longli Kang
Journal:  Hum Genomics       Date:  2018-07-27       Impact factor: 4.639

3.  Gastric Mucosal Lesions in Tibetans with High-Altitude Polycythemia Show Increased HIF-1A Expression and ROS Production.

Authors:  Kang Li; Chaohui He
Journal:  Biomed Res Int       Date:  2019-03-14       Impact factor: 3.411

4.  Genetic changes in the EPAS1 gene between Tibetan and Han ethnic groups and adaptation to the plateau hypoxic environment.

Authors:  Cuiying Li; Xiaowei Li; Jun Xiao; Juan Liu; Xiu Fan; Fengyan Fan; Huifen Lei
Journal:  PeerJ       Date:  2019-10-28       Impact factor: 2.984

5.  Unique hemoglobin dynamics in female Tibetan highlanders.

Authors:  Hiroaki Arima; Masayuki Nakano; Sweta Koirala; Hiromu Ito; Basu Dev Pandey; Kishor Pandey; Takayuki Wada; Taro Yamamoto
Journal:  Trop Med Health       Date:  2021-01-04

6.  Microarray-Based Prediction of Polycythemia after Exposure to High Altitudes.

Authors:  Haijing Wang; Daoxin Liu; Pengfei Song; Feng Jiang; Tongzuo Zhang
Journal:  Genes (Basel)       Date:  2022-07-02       Impact factor: 4.141

7.  Ethnically Tibetan women in Nepal with low hemoglobin concentration have better reproductive outcomes.

Authors:  Jang Ik Cho; Buddha Basnyat; Choongwon Jeong; Anna Di Rienzo; Geoff Childs; Sienna R Craig; Jiayang Sun; Cynthia M Beall
Journal:  Evol Med Public Health       Date:  2017-04-21

8.  Whole-Genome Sequencing Identifies the Egl Nine Homologue 3 (egln3/phd3) and Protein Phosphatase 1 Regulatory Inhibitor Subunit 2 (PPP1R2P1) Associated with High-Altitude Polycythemia in Tibetans at High Altitude.

Authors:  Luobu Gesang; Lamu Gusang; Ciren Dawa; Gawa Gesang; Kang Li
Journal:  Dis Markers       Date:  2019-11-07       Impact factor: 3.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.